While the opioid crisis has inspired a wave of new legislation by Congress, the U.S. Department of Justice (“DOJ”) has continued to increase its own response to the prevalent rate of opioid-related drug crimes with a number of new initiatives. On October 17th, Deputy Attorney General Rod Rosenstein recently delivered remarks at the America’s Health
Latest Post
More Posts
An Update on DOJ’s Health Care Fraud Enforcement Efforts Targeting the Opioid Crisis
New Draft Guidance on Adaptive Designs for Clinical Trials
New Draft Guidance on Adaptive Designs for Clinical Trials
Compliance with Florida’s “Generator” Laws
Compliance with Florida’s “Generator” Laws
DEA Proposed Rule Would Limit Drug Manufacturer’s Annual Opioid Production
DEA Proposed Rule Would Limit Drug Manufacturer’s Annual Opioid Production
As More Health Care Employers Adopt Mandatory Vaccine Policies, DOJ and HHS Push Back on Behalf of Individual Workers
Top Five Takeaways from MedPAC’s Meeting on Medicare Issues and Policy Developments – March 2018
Subscribe: Subscribe via RSS